WPG Advisers’s Amicus Therapeutics FOLD Stock Holding History

WPG Advisers’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-17	Closed	-$246	–	1565
2026 Q1	$246	Hold	17	–	–	﹤0.01%	1420
2025 Q4	$242	Hold	17	–	–	﹤0.01%	1436
2025 Q3	$134	Hold	17	–	–	﹤0.01%	1425
2025 Q2	$97	Hold	17	–	–	﹤0.01%	1416
2025 Q1	$139	Hold	17	–	–	﹤0.01%	1414
2024 Q4	$160	Buy	+17	New	+$177	﹤0.01%	1440

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

WPG Advisers's FOLD Position: Q2 2026 in Review

WPG Advisers sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 17 shares — an estimated $246 sold.

WPG Advisers first reported a position in FOLD in Q4 2024 and held it in 6 quarters. The position peaked at $246 in Q1 2026. 1 fund tracked by Wall St. Rank holds FOLD as of Q2 2026.

WPG Advisers reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
WPG Advisers sold 17 Amicus Therapeutics shares in Q2 2026, an estimated $246.
WPG Advisers first reported a position in Amicus Therapeutics in Q4 2024 and held it in 6 quarters.
WPG Advisers's Amicus Therapeutics position peaked at $246 in Q1 2026.
1 fund tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.